| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8707214 | Oral Oncology | 2018 | 8 Pages |
Abstract
The results of this study do not support the use of cixutumumab alone or with cetuximab in unselected patients with R/M HNSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Renata Ferrarotto, William N. Jr., Jennifer E. Tseng, Shanthi Marur, Dong M. Shin, Barbara Murphy, Ezra E.W. Cohen, Christopher Y. Thomas, Richard Willey, Jan Cosaert, Nusrat Harun, J. Jack Lee, Ignacio W. Wistuba, Robert I. Haddad, Bonnie S. Glisson,